Ultrasound technology is rapidly transforming from a diagnostic tool into a therapeutic innovation for brain conditions such as pain, OCD, and Parkinson’s disease. Researchers from Stanford University ...
Doctors at Shanghai Ninth People's Hospital used a brain pacemaker to treat a patient suffering from Meige syndrome, a rare involuntary movement disorder.
Parkinson's disease, traditionally believed to originate in the brain, may actually begin its journey in an unexpected ...
A small feasibility study funded by the National Institutes of Health (NIH) found that an implanted device regulated by the body’s brain activity could provide continual and improved treatment for the ...
The process of diagnosis for someone dealing with symptoms of Parkinson’s disease can sometimes leave the patient and even their healthcare provider frustrated due to the slow pace of assessment and ...
DBS, which has been transformative for conditions like Parkinson’s Disease, essential tremor and dystonia, works by implanting a ‘brain pacemaker’ that sends electrical signals to the brain.
The U.S. FDA has approved a 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease (PD). This therapy is the first of its kind, designed to address motor fluctuations ...
18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev ... boost dopamine levels in the brain and keep symptoms under control ...
as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of motor fluctuations in adults with advanced Parkinson's disease (PD). Developed by US pharma major ...
People with advanced Parkinson’s disease have a new treatment option, as the Food and Drug Administration on Thursday approved a combination therapy from AbbVie that’s designed to provide ...
On February 21, 2024, we conducted a search using the following search strategy: TI = (“Parkinson*”) AND TI = (“Deep Brain Stimulation*” OR“Electrical Stimulation of the Brain”). We limited our search ...